Author details

Full Name

Mark Noble

Affiliation

University of Rochester Medical Center

ORCID

Career Start Year

1981

Papers

139

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33368893	Erythropoietin promotes functional recovery in a mouse model of postoperative ileus.	Neurogastroenterol Motil	2021
31608497	Peripheral nerve injury and myelination: Potential therapeutic strategies.	J Neurosci Res	2020
32924936	The many roles of C1q.	Elife	2020
30901424	4-Aminopyridine as a Single Agent Diagnostic and Treatment for Severe Nerve Crush Injury.	Mil Med	2019
31093982	4-Aminopyridine attenuates muscle atrophy after sciatic nerve crush injury in mice.	Muscle Nerve	2019
29623914	Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage.	Neural Regen Res	2018
28575206	Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury.	Hum Mol Genet	2017
28168703	Erythropoietin accelerates functional recovery after moderate sciatic nerve crush injury.	Muscle Nerve	2017
27861125	4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury.	EMBO Mol Med	2016
26469940	Mutation of ataxia-telangiectasia mutated is associated with dysfunctional glutathione homeostasis in cerebellar astroglia.	Glia	2016
27593486	Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized Effects.	J Hand Surg Am	2016
27977664	Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity.	PLoS Biol	2016
25481740	Redox biology in normal cells and cancer: restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment.	Free Radic Biol Med	2015
26310626	A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.	Hum Mol Genet	2015
25633192	cFLIP is critical for oligodendrocyte protection from inflammation.	Cell Death Differ	2015
24477866	Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons.	EMBO Mol Med	2014
24458840	Cool-1-mediated inhibition of c-Cbl modulates multiple critical properties of glioblastomas, including the ability to generate tumors in vivo.	Stem Cells	2014
23642358	iOPs: a new tool for studying myelin pathologies?	Cell Stem Cell	2013
24133281	Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes.	J Neurosci	2013
24048837	MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells.	J Neurosci	2013
23606532	Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells.	EMBO Mol Med	2013
20732974	A composite likelihood approach to the analysis of longitudinal clonal data on multitype cellular systems under an age-dependent branching process.	Biostatistics	2011
22027545	Cell therapies for the central nervous system: how do we identify the best candidates?	Curr Opin Neurol	2011
21918888	Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury.	Neurotherapeutics	2011
21407803	Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury.	PLoS One	2011
21040723	Glial restricted precursor cell transplant with cyclic adenosine monophosphate improved some autonomic functions but resulted in a reduced graft size after spinal cord contusion injury in rats.	Exp Neurol	2011
21211773	Oxidative-reductionist approaches to stem and progenitor cell function.	Cell Stem Cell	2011
19508238	Saddlepoint approximations to the moments of multitype age-dependent branching processes, with applications.	Biometrics	2010
21056994	Mathematical and experimental approaches to identify and predict the effects of chemotherapy on neuroglial precursors.	Cancer Res	2010
19064774	Novel multi-modal strategies to promote brain and spinal cord injury recovery.	Stroke	2009
18430259	Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.	J Biol	2008
18803859	Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury.	J Biol	2008
17298174	Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function.	PLoS Biol	2007
16643674	Astrocytes derived from glial-restricted precursors promote spinal cord repair.	J Biol	2006
16990388	Cancer stem cells.	N Engl J Med	2006
17125495	CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.	J Biol	2006
16707014	Stochastic modeling of oligodendrocyte generation in cell culture: model validation with time-lapse data.	Theor Biol Med Model	2006
16472202	Implications for CNS repair of redox modulation of cell survival, division and differentiation.	Curr Alzheimer Res	2006
15737094	A stochastic model to analyze clonal data on multi-type cell populations.	Biometrics	2005
17142878	Ethics in the trenches: a multifaceted analysis of the stem cell debate.	Stem Cell Rev	2005
16356108	Redox regulation of precursor cell function: insights and paradoxes.	Antioxid Redox Signal	2005
15723074	EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy.	Nat Med	2005
15748733	Estimating the life-span of oligodendrocytes from clonal data on their development in cell culture.	Math Biosci	2005
14675726	The possible role of myelin destruction as a precipitating event in Alzheimer's disease.	Neurobiol Aging	2004
15530870	Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration.	Exp Neurol	2004
14697351	Getting a GR(i)P on oligodendrocyte development.	Dev Biol	2004
15036880	The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity.	Trends Neurosci	2004
12846992	Redox state as a central modulator of precursor cell function.	Ann N Y Acad Sci	2003
12966219	The cortical ancestry of oligodendrocytes: common principles and novel features.	Dev Neurosci	2003
14637087	Directed nerve outgrowth is enhanced by engineered glial substrates.	Exp Neurol	2003

1 - 50 of 139

Arantxa Cebrian-Silla

University of California San Francisco

Career Start Year 2012

Number of shared co-authors 0

Yan Liu

University of Wisconsin

Career Start Year 2009

Number of shared co-authors 0

Lesley S Chaboub

Center for Neuroregeneration, Houston Methodist Research Institute

Career Start Year 2009

Number of shared co-authors 0

Vicente Herranz-P??rez

Cavanilles Institute, University of Valencia

Career Start Year 2006

Number of shared co-authors 0

Yu Alex Zhang

Beijing Institute for Brain Disorders

Career Start Year 2000

Number of shared co-authors 0

Anders I Persson

University of California san francisco

Career Start Year 1998

Number of shared co-authors 0

Nathalie Spassky

Ecole Normale Superieure, Institut de Biologie de l'ENS, France CNRS, France INSERM

Career Start Year 1998

Number of shared co-authors 0

Olivier Raineteau

Universite Claude Bernard Lyon 1, Inserm, Stem Cell and Brain Research Institute U8

Career Start Year 1998

Number of shared co-authors 0

Claudia Mandl

Interdisciplinary Center for Neurosciences (IZN), University of Heidelberg

Career Start Year 1994

Number of shared co-authors 0

Paul Olivier

Center for Global Infectious Disease Research, Seattle Children's Research Institute

Career Start Year 1993

Number of shared co-authors 0

Anke Meyer-Franke

Gladstone Institutes

Career Start Year 1993

Number of shared co-authors 0

Daniel A Lim

University of California san francisco

Career Start Year 1993

Number of shared co-authors 1

Bj??rn Scheffler

German Cancer Research Center (DKFZ)

Career Start Year 1992

Number of shared co-authors 0

Verdon Taylor

University of Basel

Career Start Year 1991

Number of shared co-authors 0

Luca Bonfanti

Neuroscience Institute Cavalieri Ottolenghi

Career Start Year 1991

Number of shared co-authors 1

Francesca Ciccolini

Universitat Heidelberg

Career Start Year 1989

Number of shared co-authors 0

Karen Gorse

9Virginia Commonwealth University

Career Start Year 1988

Number of shared co-authors 1

Dragan Maric

National Institute of Neurological Disorders and Stroke

Career Start Year 1986

Number of shared co-authors 0

Arturo Alvarez-Buylla

University of California san francisco

Career Start Year 1985

Number of shared co-authors 1

Jeffrey S Schweitzer

Massachusetts General Hospital, Harvard Medical School

Career Start Year 1984

Number of shared co-authors 0

David H Rowitch

Wellcome Trust-Medical Research Council Stem Cell Institute and.

Career Start Year 1983

Number of shared co-authors 0

Steven A Goldman

Center for Translational Neuromedicine, University of Rochester Medical Center

Career Start Year 1982

Number of shared co-authors 1

Jos?? Manuel Garc??a-Verdugo

Cavanilles Institute, University of Valencia

Career Start Year 1981

Number of shared co-authors 1

Alan Mackay-Sim

Northern Clinical School, Sydney Medical School, University of Sydney

Career Start Year 1980

Number of shared co-authors 0

Evan Y Snyder

Sanford Burnham Prebys Medical Discovery Institute

Career Start Year 1979

Number of shared co-authors 3

John W Bigbee

Virginia Commonwealth University

Career Start Year 1977

Number of shared co-authors 1

Scott R VandenBerg

University of California san francisco

Career Start Year 1975

Number of shared co-authors 0

Mary E Hatten

The Rockefeller University

Career Start Year 1974

Number of shared co-authors 0

Arnold R Kriegstein

University of California san francisco

Career Start Year 1974

Number of shared co-authors 0

Richard L Sidman

Harvard Medical School

Career Start Year 1951

Number of shared co-authors 1

row(s) 1 - 30 of 30

Margot Mayer-Pr??schel

University of Rochester

Co-authored papers 47

Guus Wolswijk

Netherlands Institute for Brain Research

Co-authored papers 13

Damian R Wren

Frimley Health NHS Foundation Trust

Co-authored papers 9

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Co-authored papers 8

Susan C Barnett

University of Glasgow, University Place

Co-authored papers 7

Andrew K Groves

Baylor College of Medicine

Co-authored papers 7

Parmjit S Jat

UCL Institute of Prion Diseases

Co-authored papers 5

Alan Entwistle

The Ludwig Institute for Cancer Research